About me
Stephanie Choi, Ph.D. is currently a Director in Global Regulatory and Scientific Policy at EMD Serono. Her current interests relate to regulatory policy in oncology, CDx, and RWE. Prior to EMD Serono, she worked as a regulatory strategist at Jazz Pharmaceuticals supporting early product development for cannabinoids. She also worked at FDA's Office of Generic Drugs for over 12 years and provided scientific expertise on complex generics, drafted numerous guidances, and lead the GDUFA regulatory science research program.
